Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

RANI

Rani Therapeutics Holdings Inc

Feb 10 • 04:00PM ET

1.34

+0.07 5.51 %

Healthcare • Biotechnology • USA • NASD

Peers: REGN BMRN SRPT ASND CRSP FATE NTLA EDIT BLUE LBPH

| Held by: VTI VXF IWC IBBQ BIB

Index	-	P/E	-	EPS (ttm)	-0.79	Insider Own	38.07%	Shs Outstand	97.55M	Perf Week	8.94%
Market Cap	162.84M	Forward P/E	-	EPS next Y	-0.27	Insider Trans	-7.66%	Shs Float	60.42M	Perf Month	-4.29%
Enterprise Value	171.64M	PEG	-	EPS next Q	-0.05	Inst Own	16.90%	Short Float	22.86%	Perf Quarter	-33.66%
Income	-28.32M	P/S	135.70	EPS this Y	59.52%	Inst Trans	9.00%	Short Ratio	6.47	Perf Half Y	168.00%
Sales	1.20M	P/B	-	EPS next Y	36.47%	ROA	-105.50%	Short Interest	13.81M	Perf YTD	-0.74%
Book/sh	-0.16	P/C	35.09	EPS next 5Y	35.44%	ROE	-1372.59%	52W High	3.87 -65.37%	Perf Year	-11.84%
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	-35.62% 4.78%	ROIC	-	52W Low	0.39 246.25%	Perf 3Y	-75.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-27.67% 0.98%	Gross Margin	18.33%	Volatility	11.28% 6.66%	Perf 5Y	-
Dividend TTM	-	EV/Sales	143.03	EPS Y/Y TTM	25.08%	Oper. Margin	-3418.25%	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.26	Sales Y/Y TTM	-	Profit Margin	-2359.58%	RSI (14)	51.32	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.26	EPS Q/Q	50.47%	SMA20	2.17%	Beta	0.43	Target Price	9.25
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-4.26%	Rel Volume	0.62	Prev Close	1.27
Employees	105	LT Debt/Eq	-	Earnings	Nov 06 AMC	SMA200	36.49%	Avg Volume	2.13M	Price	1.34
IPO	Jul 30, 2021	Option/Short	Yes / No	EPS/Sales Surpr.	21.31% -	Trades		Volume	1,320,977	Change	5.51%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-24	Initiated	Oppenheimer	Outperform	$17
Jun-14-24	Initiated	Maxim Group	Buy	$15
Jun-13-24	Initiated	Rodman & Renshaw	Buy	$10
Apr-17-23	Resumed	BTIG Research	Buy	$24
Oct-11-22	Initiated	UBS	Buy	$15
Jul-27-22	Initiated	H.C. Wainwright	Buy	$22
Jun-13-22	Initiated	Wedbush	Outperform	$28

Jan-28-26 07:00AM	Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer (GlobeNewswire)
Jan-24-26 08:45AM	Largest borrow rate increases among liquid names (TipRanks)
Jan-08-26 07:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill for the Treatment of Obesity in Collaboration with ProGen (GlobeNewswire)
Nov-24-25 04:05PM	Rani Therapeutics to Participate in the Evercore Healthcare Conference (GlobeNewswire)
Nov-06-25 04:30PM	Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update (GlobeNewswire) -9.20% -11.01%
08:00AM	Loading…
Oct-30-25 08:00AM	Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill Capsule at ObesityWeek 2025 (GlobeNewswire) -12.65%
Oct-26-25 06:05AM	H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential (Insider Monkey)
Oct-23-25 04:05PM	Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors (GlobeNewswire) -13.46% -12.92%
04:01PM	Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules (GlobeNewswire)
Oct-17-25 01:12PM	Why Rani Therapeutics (RANI) Stock Is Soaring Friday? (GuruFocus.com) +248.27%
07:31AM	Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules (GlobeNewswire)
07:30AM	Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing (GlobeNewswire)
Aug-07-25 04:05PM	Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-15-25 09:00AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering (GlobeNewswire) -38.92%
Jul-14-25 05:00AM	Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery (GlobeNewswire) +8.45%
08:00AM	Loading…
May-19-25 08:00AM	Rani Therapeutics Announces Research Agreement with Chugai (GlobeNewswire) +9.27%
May-13-25 04:05PM	Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update (GlobeNewswire) -21.42% +15.59%
Apr-01-25 10:55AM	Q4 2024 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:05AM	Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ... (GuruFocus.com)
Mar-31-25 07:15PM	Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript (Seeking Alpha) -7.35%
04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-26-25 04:05PM	Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill Capsule, to Subcutaneously Administered PG-102 (GlobeNewswire) -6.29%
Mar-25-25 06:00PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-05-25 04:05PM	Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill HC (GlobeNewswire) +5.11% +14.58%
Nov-14-24 08:00AM	Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-07-24 04:05PM	Rani Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-17-24 08:00AM	Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Oct-15-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants (GlobeNewswire) -33.33%
Oct-13-24 06:01AM	Oppenheimer Predicts up to 740% Rally for These 2 Strong Buy Stocks (TipRanks)
Oct-08-24 04:05PM	Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +7.31%
04:05PM	Loading…
Sep-03-24 04:05PM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire) -7.50%
Aug-06-24 04:05PM	Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-29-24 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jul-22-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering (GlobeNewswire)
Jun-24-24 07:00AM	Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment (GlobeNewswire)
May-16-24 10:15AM	UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating (MT Newswires)
May-14-24 08:00AM	Rani Therapeutics to Participate in May Investor Conferences (GlobeNewswire) -5.40%
May-09-24 08:00AM	Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill Capsule at Digestive Disease Week 2024 (GlobeNewswire) -5.17%
May-07-24 09:06PM	Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates (GuruFocus.com)
May-06-24 09:55PM	RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024 (InvestorPlace) +5.73%
04:05PM	Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-21-24 09:45AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:35AM	Q4 2023 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-15-24 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +6.25%
Feb-05-24 08:00AM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) (GlobeNewswire) +5.73%
Dec-14-23 08:00AM	Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Dec-07-23 12:00PM	What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock (Zacks)
Nov-08-23 05:53PM	Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments (GuruFocus.com)
04:05PM	Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:05PM	Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 08:00AM	The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study (GlobeNewswire)
Oct-19-23 04:05PM	Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study (GlobeNewswire)
Oct-12-23 04:05PM	Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (GlobeNewswire)
Sep-18-23 08:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43) (GlobeNewswire)
Sep-07-23 04:05PM	Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies (GlobeNewswire)
Sep-06-23 08:00AM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Aug-11-23 04:05PM	Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Aug-04-23 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jun-21-23 08:00AM	Rani Therapeutics Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference (GlobeNewswire)
Jun-08-23 08:00AM	Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference (GlobeNewswire)
Jun-05-23 08:00AM	Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105 (GlobeNewswire)
Jun-01-23 08:00AM	Rani Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:00AM	Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference (GlobeNewswire)
May-24-23 08:00AM	Rani Therapeutics Appoints Kate McKinley as Chief Business Officer (GlobeNewswire)
May-17-23 09:50AM	2 Strong Buy Penny Stocks With Over 400% Upside on the Horizon (TipRanks) +12.25%
May-10-23 04:05PM	Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire) -8.84%
Apr-26-23 06:46AM	Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) last week's 14% decline must have disappointed private companies who have a significant stake (Simply Wall St.)
Apr-25-23 08:00AM	Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-11-23 08:00AM	Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-23 07:12AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -6.89%
Mar-16-23 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +5.71%
Jan-09-23 08:30AM	Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment (GlobeNewswire)
Jan-05-23 04:05PM	Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update (GlobeNewswire) +8.12%
Dec-06-22 04:05PM	Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study (GlobeNewswire) +9.67%
Nov-17-22 05:30AM	Private companies among Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders, saw gain in holdings value after stock jumped 21% last week (Simply Wall St.)
Nov-10-22 05:25PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-09-22 04:05PM	Rani Therapeutics to Present at the Stifel Healthcare Conference (GlobeNewswire)
Oct-28-22 09:55AM	Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-24-22 08:30AM	Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update (GlobeNewswire) -10.03%
Sep-27-22 09:06AM	8 Best Stocks to Buy According to Billionaire Marc Lasry (Insider Monkey)
Sep-06-22 04:05PM	Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 11:47PM	Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock (GlobeNewswire) -25.89% +37.55%
Aug-10-22 05:45PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:28PM	Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
04:28PM	Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
04:23PM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis (GlobeNewswire)
Aug-08-22 08:30AM	Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development (GlobeNewswire)
Aug-03-22 07:48AM	Investors in Rani Therapeutics Holdings (NASDAQ:RANI) have made a return of 16% over the past year (Simply Wall St.)
May-11-22 04:05PM	Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -5.75%
May-04-22 03:09PM	Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth (Simply Wall St.)
May-03-22 04:05PM	Rani Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) -6.19%
07:00AM	Rani Therapeutics RaniPill Capsule Named Winner in the Health Category of Fast Companys 2022 World Changing Ideas Awards (GlobeNewswire)
Apr-07-22 04:05PM	Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-23-22 08:38PM	Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022 (GlobeNewswire)
08:00AM	Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis (GlobeNewswire)
Feb-23-22 08:00AM	Rani Therapeutics Unveils High-Capacity RaniPill Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results (GlobeNewswire) -8.47%

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
IMRAN MIR A	Director	Oct 23 '25	Buy	0.60	2,083,334	1,260,417	2,083,334	Oct 27 07:24 PM
South Cone Investments Limited	10% Owner	Oct 21 '25	Sale	2.77	4,000,000	11,074,000	2,379,194	Oct 22 06:57 PM
South Cone Investments Limited	10% Owner	Oct 20 '25	Sale	2.41	1,923,000	4,637,314	6,379,194	Oct 22 06:57 PM

Open in Screener

FTCI

FTC Solar Inc

Feb 10 • 04:00PM ET

10.03

+0.39 4.05 %

Technology • Solar • USA • NASD

Peers: SEDG ENPH RUN CSIQ JKS FSLR MAXN ACA SHLS

| Held by: VTI VXF IWC CTEX DFAS

Index	-	P/E	-	EPS (ttm)	-4.04	Insider Own	36.05%	Shs Outstand	14.94M	Perf Week	-3.09%
Market Cap	149.86M	Forward P/E	-	EPS next Y	-0.72	Insider Trans	-2.39%	Shs Float	9.55M	Perf Month	-15.71%
Enterprise Value	143.15M	PEG	-	EPS next Q	-0.28	Inst Own	5.69%	Short Float	9.58%	Perf Quarter	21.28%
Income	-55.42M	P/S	1.87	EPS this Y	11.20%	Inst Trans	5.32%	Short Ratio	4.60	Perf Half Y	114.32%
Sales	80.03M	P/B	-	EPS next Y	78.79%	ROA	-54.54%	Short Interest	0.91M	Perf YTD	-8.07%
Book/sh	-0.92	P/C	6.15	EPS next 5Y	-	ROE	-664.69%	52W High	12.75 -21.33%	Perf Year	195.87%
Cash/sh	1.63	P/FCF	-	EPS past 3/5Y	32.35% -18.48%	ROIC	-1583.94%	52W Low	2.13 370.89%	Perf 3Y	-64.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-44.06% -2.27%	Gross Margin	-12.01%	Volatility	8.97% 7.68%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.79	EPS Y/Y TTM	-7.16%	Oper. Margin	-53.97%	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.35	Sales Y/Y TTM	39.53%	Profit Margin	-69.25%	RSI (14)	43.67	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.66	EPS Q/Q	-33.24%	SMA20	-7.56%	Beta	1.44	Target Price	14.38
Payout	-	Debt/Eq	-	Sales Q/Q	156.81%	SMA50	-6.27%	Rel Volume	0.65	Prev Close	9.64
Employees	202	LT Debt/Eq	-	Earnings	Nov 12 BMO	SMA200	39.04%	Avg Volume	198.80K	Price	10.03
IPO	Apr 28, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-184.75% 23.27%	Trades		Volume	129,424	Change	4.05%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-25	Upgrade	Roth Capital	Neutral → Buy
Nov-13-25	Reiterated	TD Cowen	Buy	$8 → $12.50
Mar-14-24	Downgrade	ROTH MKM	Buy → Neutral
Nov-09-23	Downgrade	Northland Capital	Outperform → Market Perform	$0.65
Aug-15-23	Downgrade	UBS	Buy → Neutral	$4 → $2.50
Apr-13-23	Initiated	H.C. Wainwright	Buy	$5
Mar-15-23	Upgrade	BofA Securities	Underperform → Buy	$2 → $3.50
Jul-19-22	Upgrade	Piper Sandler	Underweight → Neutral	$2 → $3.50
Jun-06-22	Upgrade	ROTH Capital	Neutral → Buy
May-23-22	Initiated	Northland Capital	Outperform	$7
Apr-21-22	Downgrade	Piper Sandler	Neutral → Underweight	$4 → $3
Apr-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4
Jan-24-22	Downgrade	ROTH Capital	Buy → Neutral	$15 → $4
Jan-14-22	Downgrade	BofA Securities	Neutral → Underperform	$9 → $5
Dec-14-21	Initiated	Colliers Securities	Buy	$13
Oct-20-21	Upgrade	Barclays	Equal Weight → Overweight	$11 → $9
Jun-10-21	Initiated	Piper Sandler	Overweight	$15
Jun-09-21	Downgrade	BofA Securities	Buy → Neutral
May-24-21	Initiated	UBS	Buy	$13
May-24-21	Initiated	ROTH Capital	Buy	$15

Show Previous Ratings

Jan-14-26 09:40AM	Is Forum Energy Technologies (FET) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
Jan-13-26 08:02AM	FTC Solar Appoints Wes Fuller VP, North America Utility Sales (GlobeNewswire)
Jan-07-26 07:33AM	CSIQ Benefits From Strong Solar and Energy Storage Growth Momentum (Zacks)
Dec-29-25 08:48AM	First Solar's Expanding Footprint Positions It for Sustained Growth (Zacks)
Dec-17-25 07:56AM	SolarEdge Technologies to Benefit From Rising U.S. Solar Demand (Zacks) -5.85%
08:00AM	Loading…
Dec-15-25 08:00AM	FTC Solar Appoints Anthony Carroll to Board of Directors (GlobeNewswire)
Dec-09-25 09:40AM	Is FTC Solar (FTCI) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
08:19AM	4 Solar Stocks to Watch With Robust Growth & Steady Long-Term Outlook (Zacks)
Nov-20-25 09:40AM	Are Oils-Energy Stocks Lagging DAQO New Energy (DQ) This Year? (Zacks) -6.33%
Nov-12-25 04:03PM	FTC Solar Inc (FTCI) Q3 2025 Earnings Call Highlights: Surpassing Revenue Expectations and ... (GuruFocus.com) +49.19%
07:45AM	FTC Solar (FTCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:41AM	FTC Solar: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-11-25 08:30AM	FTC Solar publishes white paper on Automation-Ready Construction with 1P Pioneer Tracker (GlobeNewswire)
Nov-10-25 05:55PM	Vaalco Energy (EGY) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -10.76%
06:05PM	Loading…
Nov-06-25 06:05PM	Sunrun (RUN) Q3 Earnings and Revenues Top Estimates (Zacks) -5.15%
Nov-05-25 08:30AM	SolarEdge Technologies (SEDG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) +7.83%
Oct-30-25 08:02AM	FTC Solar to Announce Third Quarter 2025 Financial Results Wednesday, November 12, 2025 (GlobeNewswire)
Oct-28-25 05:40PM	Tigo Energy, Inc. (TYGO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Sep-09-25 09:00AM	FTC Solar Launches Enhanced Pioneer+ Terrain Following Tracker at RE+ to Minimize Grading and Speed Installation (GlobeNewswire)
Sep-07-25 09:57AM	FTC Solar Secures a 1GW Solar Tracker, Software Agreement with Levona Renewables (Insider Monkey)
Sep-03-25 08:30AM	FTC Solar Launches Automated 80 High Angle Stow for 1P Pioneer Tracker to Maximize Hail Protection (GlobeNewswire)
Aug-26-25 08:04AM	FTC Solar Announces 1GW Tracker Agreement with Levona Renewables (GlobeNewswire) +5.76%
Aug-18-25 08:03AM	FTC Solar to Participate in Upcoming Investor Events (GlobeNewswire) +5.14%
Aug-14-25 07:00AM	FTC Solar Launches Pioneer+ High Wind Tracker to Expand Resilient Solar Deployment Options (GlobeNewswire)
Aug-05-25 07:45AM	FTC Solar (FTCI) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -18.46%
06:39AM	FTC Solar: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 10:11AM	FTC Solar Inc (FTCI) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +10.54%
Jul-31-25 08:30AM	FTC Solar Launches Safe Harbor Strategy Leveraging Module-Agnostic Universal Torque Tubes & Engineering Services Expertise to Enable Tax Credit Certainty (GlobeNewswire)
05:30PM	Loading…
Jul-29-25 05:30PM	Tigo Energy, Inc. (TYGO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-23-25 08:00AM	FTC Solar to Announce Second Quarter 2025 Financial Results Tuesday, August 5, 2025 (GlobeNewswire) +10.02%
Jul-16-25 09:30AM	Solar Tracker Market Global Forecast and Company Analysis Report 2025-2029, with Profiles of Nextracker, Array Technologies, PVHardware, Soltec, Gamechange Solar, Arctech, FTC Solar, and More (GlobeNewswire)
Jul-08-25 08:25AM	FTC Solar enters $75M strategic financing facility (TipRanks)
Jul-07-25 08:02AM	FTC Solar Announces $75 Million Strategic Financing (GlobeNewswire)
May-21-25 11:15AM	ITC makes affirmative decision in Crystalline Silicon PV Cell investigations (TipRanks)
10:30AM	Trump Trade: Conservatives fight to end IRA tax credits sooner (TipRanks)
May-20-25 11:30AM	Solar stocks slip as conservatives fight to end IRA tax credits sooner (TipRanks) -5.17%
May-13-25 08:02AM	FTC Solar to Participate in Upcoming Investor Conferences (GlobeNewswire) +8.99%
May-02-25 03:07AM	FTC Solar Inc (FTCI) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... (GuruFocus.com) -5.72%
01:47AM	Q1 2025 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-25 04:10PM	FTC Solar, Inc. (FTCI) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:50AM	FTC Solar (FTCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:55AM	FTC Solar: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 10:01AM	Array Technologies, Inc. (ARRY) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-24-25 08:01AM	FTC Solar to Announce First Quarter 2025 Financial Results Thursday, May 1, 2025 (GlobeNewswire) +10.99%
Apr-18-25 11:15AM	Exxon, Occidental projects at risk due to DOGE cuts, WSJ reports (TipRanks)
Apr-08-25 08:00AM	FTC Solar Introduces Revolutionary Dual-Row Configuration for 1P Pioneer Tracker : Industry's Highest East-West Slope Tolerance for a linked tracker (GlobeNewswire) -9.96%
Apr-02-25 08:36AM	FTC Solar price target lowered to $5 from $10 at TD Cowen (TipRanks) +7.27%
Apr-01-25 12:16PM	Rocket acquires Mr. Cooper, Musks xAI acquires X: Morning Buzz (TipRanks)
03:03AM	FTC Solar Inc (FTCI) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
12:41AM	Q4 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-31-25 02:18PM	FTC Solar, Inc. (FTCI) Q3 2024 Earnings Call Transcript (Seeking Alpha) +14.80%
07:40AM	FTC Solar (FTCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:48AM	FTC Solar: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Fourth Quarter 2024 Financial Results (GlobeNewswire)
Mar-24-25 08:01AM	FTC Solar to Announce Fourth Quarter and Full Year 2024 Financial Results Monday, March 31, 2025 (GlobeNewswire) +7.12%
Jan-14-25 08:00AM	FTC Solar Appoints Kent James Chief Commercial Officer (GlobeNewswire)
Dec-04-24 04:37PM	FTC Solar Announces Closing of Promissory Note Private Placement (GlobeNewswire) -6.48% -6.27%
Nov-28-24 08:11AM	FTC Solar announces 1-for-10 reverse stock split (TipRanks)
Nov-27-24 08:02AM	FTC Solar Announces Reverse Stock Split (GlobeNewswire) -9.08%
Nov-13-24 02:10AM	FTC Solar Inc (FTCI) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 11:34PM	Q3 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents) -12.70%
07:45AM	FTC Solar (FTCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:42AM	FTC Solar: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:25AM	FTC Solar Inc (FTCI) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com) +7.00%
Nov-05-24 08:29AM	FTC Solar to supply trackers for 1GW Dunlieh Energy solar projects (Power Technology)
08:02AM	FTC Solar to Announce Third Quarter Financial Results Tuesday, November 12, 2024 (GlobeNewswire)
Nov-04-24 08:30AM	FTC Solar Announces 1GW Tracker Supply Agreement with Dunlieh Energy (GlobeNewswire)
Oct-24-24 08:25AM	FTC Solar to supply 1GW of projects for Sandhills Energy (TipRanks) +7.61%
Oct-23-24 08:02AM	FTC Solar to Supply Approximately 1GW of Projects for Sandhills Energy (GlobeNewswire)
Oct-09-24 05:37PM	FTC Solar Inc (FTCI) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)
Oct-08-24 08:50AM	Fast-paced Momentum Stock FTC Solar (FTCI) Is Still Trading at a Bargain (Zacks) -6.31%
Sep-20-24 10:23AM	FTC Solar, Inc. (FTCI): A Bull Case Theory (Insider Monkey) -6.85%
Sep-10-24 04:01PM	FTC Solar Announces Multi-Year Tracker Supply Agreement with Strata Clean Energy (GlobeNewswire) +5.68% +104.00%
Aug-28-24 08:00AM	FTC Solar to Participate at RE+ Event September 9-12 (GlobeNewswire) -5.78%
Aug-16-24 04:58PM	FTC Solar Announces Inducement Grant of Employee Inducement Award (GlobeNewswire)
08:38AM	FTC Solar Appoints Pablo Barahona to Board of Directors (GlobeNewswire)
Aug-15-24 07:45AM	FTC Solar Announces Resignation of Board Member (GlobeNewswire) -5.55%
Aug-09-24 12:47AM	Q2 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-08-24 07:40AM	FTC Solar (FTCI) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -33.40%
06:38AM	FTC Solar: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 04:01PM	FTC Solar to Announce Second Quarter Financial Results Thursday, August 8, 2024 (GlobeNewswire)
Jul-23-24 04:01PM	FTC Solar Appoints Yann Brandt as New CEO (GlobeNewswire) +6.97%
May-31-24 06:39PM	Is FTC Solar, Inc. (NASDAQ:FTCI) the Best Renewable Energy Penny Stock According to Hedge Funds? (Insider Monkey) +6.96%
06:29PM	10 Best Renewable Energy Penny Stocks to Invest In (Insider Monkey)
May-30-24 10:39AM	FTC Solar Introduces Automated Hail Stow Solution to Mitigate Solar Panel Damage (PR Newswire)
May-15-24 08:15AM	FTC Solar Announces New Sales and Leadership Appointments (GlobeNewswire)
May-13-24 10:35AM	Piper Sandler Trims FTC Solar Price Target to $0.40 From $0.50, Maintains Neutral Rating (MT Newswires) +7.04%
03:04AM	FTC Solar Inc (FTCI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-11-24 09:42AM	FTC Solar, Inc. (NASDAQ:FTCI) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:00AM	Q1 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-24 10:52AM	FTCI Stock Earnings: FTC Solar Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace) -15.33%
06:41AM	FTC Solar: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 04:01PM	FTC Solar to Announce First Quarter Financial Results Friday, May 10, 2024 (GlobeNewswire) +7.28%
May-01-24 10:01AM	Earnings Preview: FTC Solar (FTCI) Q1 Earnings Expected to Decline (Zacks)

FTC Solar, Inc. provides solar tracker systems, technology, software, and engineering services. Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation to the sun. The company was founded by David Springer and Ahmad R. Chatila in 2017 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Behnen Cathy	CHIEF FINANCIAL OFFICER	Dec 30 '25	Sale	10.93	1,646	17,991	143,534	Dec 31 05:26 PM
Aminpour Sasan	Chief Operating Officer	Dec 30 '25	Sale	10.93	3,239	35,402	269,734	Dec 31 05:26 PM
Brandt Yann	Chief Executive Officer	Dec 30 '25	Sale	10.84	37,775	409,376	776,425	Dec 31 05:00 PM
YANN BRANDT	OFFICER	Dec 30 '25	Proposed Sale	10.79	37,775	407,499		Dec 30 05:44 PM
SASAN AMINPOUR	OFFICER	Dec 30 '25	Proposed Sale	10.88	3,239	35,229		Dec 30 05:42 PM
MARY CATHY BEHNEN	OFFICER	Dec 30 '25	Proposed Sale	10.93	1,646	17,987		Dec 30 05:39 PM
Carroll Anthony	Director	Dec 16 '25	Buy	9.53	10,638	101,380	24,205	Dec 18 08:00 AM
Springer David	Director	Nov 18 '25	Sale	8.98	100,000	898,000	689,222	Nov 20 06:00 PM
Springer David	Director	Nov 18 '25	Proposed Sale	9.60	100,000	960,000		Nov 18 05:00 PM
Chatila Ahmad R	Director	Apr 02 '25	Buy	2.93	16,740	49,048	1,984,708	Apr 03 09:00 AM
Chatila Ahmad R	Director	Apr 01 '25	Buy	2.91	16,922	49,243	1,967,968	Apr 02 04:30 PM
Behnen Cathy	CHIEF FINANCIAL OFFICER	Apr 01 '25	Sale	2.63	2,640	6,943	949,349	Apr 02 04:30 PM
Behnen Cathy	Officer	Apr 01 '25	Proposed Sale	2.58	2,640	6,812		Apr 01 10:53 AM

RANI

Rani Therapeutics Holdings Inc

FTCI

FTC Solar Inc

Upgrade your FINVIZ experience